Bryostatin 1 activates T cells that have antitumor activityTUTTLE, T. M; INGE, T. H; WIRT, C. P et al.Journal of immunotherapy. 1992, Vol 12, Num 2, pp 75-81, issn 1053-8550Article

Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patientsTUTTLE, T. M; ANDERSON, B. W; THOMPSON, W. E et al.Clinical cancer research. 1998, Vol 4, Num 8, pp 2015-2024, issn 1078-0432Article

Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytesBALDWIN, N. G; RICE, C. D; TUTTLE, T. M et al.Journal of neuro-oncology. 1997, Vol 32, Num 1, pp 19-28, issn 0167-594XArticle

Postischemic extremities exhibit immediate release of tumor necrosis factorSTERNBERGH, W. C; TUTTLE, T. M; MAKHOUL, R. G et al.Journal of vascular surgery. 1994, Vol 20, Num 3, pp 474-481, issn 0741-5214Article

Oncogene products represent potential targets of tumor vaccinesTUTTLE, T. M.Cancer immunology and immunotherapy. 1996, Vol 43, Num 3, pp 135-141, issn 0340-7004Article

Bryostatin 1-activated T cells can traffic and mediate tumor regressionTUTTLE, T. M; BETHKE, K. P; INGE, T. H et al.The Journal of surgical research. 1992, Vol 52, Num 6, pp 543-548, issn 0022-4804Conference Paper

Evidence for cyclophosphamide-induced transitional cell carcinoma in a renal transplant patientTUTTLE, T. M; MELVILLE WILLIAMS, G; MARSHALL, F. F et al.The Journal of urology. 1988, Vol 140, Num 5, pp 1009-1011, issn 0022-5347, 3 p.Article

Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. DiscussionMCMASTERS, K. M; TUTTLE, T. M; LEACH, S. D et al.The American journal of surgery. 1997, Vol 174, Num 6, pp 605-609, issn 0002-9610Conference Paper

Acivation of CD8⁺ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophoreTUTTLE, T. M; INGE, T. H; MCGRADY, C. M et al.Journal of immunotherapy. 1992, Vol 12, Num 1, pp 32-40, issn 1053-8550Article

Activation and growth of murine tumor-specific T-cells which have In vivo activity with bryostatin 1TUTTLE, T. M; INGE, T. H; BETHKE, K. P et al.Cancer research (Baltimore). 1992, Vol 52, Num 3, pp 548-553, issn 0008-5472Article

Surgery alone is adequate treatment for early stage soft tissue sarcoma of the extremityAL-REFAIE, W. B; HABERMANN, E. B; JENSEN, E. H et al.British journal of surgery. 2010, Vol 97, Num 5, pp 707-713, issn 0007-1323, 7 p.Article

Sentinel lymph node biopsy for breast cancer : A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is usedMCMASTERS, K. M; TUTTLE, T. M; CERRITO, P. B et al.Journal of clinical oncology. 2000, Vol 18, Num 13, pp 2560-2566, issn 0732-183XArticle

Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer : Results of a multi-institutional studyMARTIN, R. C. G. II; EDWARDS, M. J; TATE, P. S et al.Surgery. 2000, Vol 128, Num 2, pp 139-144, issn 0039-6060Conference Paper

γ-interferon plays a key role in T-cell-induced tumor regressionTUTTLE, T. M; MCCRADY, C. W; INGE, T. H et al.Cancer research (Baltimore). 1993, Vol 53, Num 4, pp 833-839, issn 0008-5472Article